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Abstract 
 
Biological signaling pathways employ a vast array of integral membrane proteins that 
process and interpret the chemical, electrical, and mechanical signals that are delivered to 
cells.  Among these proteins, ligand gated ion channels (LGIC) are therapeutic targets for 
Alzheimer’s disease, Schizophrenia, drug addiction, and learning and memory.  High-
resolution structural data on neuroreceptors are only just becoming available, yet the 
functional importance of particular structural features can be challenging.   
The primary focus of the present work is to gain a chemical scale understanding of 
the ligand-receptor binding determinants of LGICs.  In particular, these studies explore 
drug-receptor interactions at the nicotinic acetylcholine receptor (nAChR), the most 
extensively studied members of the Cys-loop family of LGICs.  The present study 
utilizes in vivo nonsense suppression methodology to perform chemical scale 
investigations of nAChR agonist activity.   
The binding of three distinct agonists–acetylcholine (ACh), nicotine, and epibatidine-
to the nicotinic acetylcholine receptor (nAChR) has been probed using unnatural amino 
acid mutagenesis.  ACh makes a cation-π interaction with Trp α149, while nicotine 
employs a hydrogen bond to a backbone carbonyl in the same region of the agonist 
binding site.  The nicotine analogue epibatidine achieves its high potency by taking 
advantage of both the cation-π interaction and the backbone hydrogen bond.  
Nonsense suppression was also utilized to probe the importance of residues outside of 
the binding box in nAChR function.  These studies demonstrate a structural role of the 
highly conserved αD89 residue in stabilizing the agonist binding site near αW149.  In 
addition to outer shell residue, αK145 is shown to be important for proper nAChR 
  
viii
function.  In combination with additional evidence from other recent advances, this site is 
proposed to be important in initiating the nAChR channel gating pathway.  
Residues outside the aromatic binding site were also examined through computational 
protein design studies.  Results from these studies identify outer shell mutations 116Q 
and 57R (AChBP numbering) that enhance nAChR specificity for nicotine, over ACh and 
epibatidine compared to wild-type receptors. 
Finally, a series of cationic polyamides were shown to enhance polyamide affinity 
while maintaining specificity by varying the number, relative spacing, and linker length 
of aminoalkyl side chains.   
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